Products Affected - Description
Bacitracin 500 unit/gram Ointment, Altaire
30 gram tube (NDC 59390-0026-17) - discontinued
Reason for the Shortage
Altaire discontinued topical bacitracin ointment in 2015.
Bacitracin 500 unit/gram Ointment, Actavis
15 gram tube (NDC 00472-1105-34)
30 gram tube (NDC 00472-1105-56)
Bacitracin 500 unit/gram Ointment, G&W Labs
30 gram tube (NDC 00713-0280-31)
Bacitracin 500 unit/gram Ointment, Perrigo
0.9 gram, unit-dose, 144 count (NDC 45802-0060-70)
15 gram tube (NDC 45802-0060-01)
30 gram tube (NDC 45802-0060-03)
Bacitracin 500 unit/gram Ointment, Qualitest
30 gram tube (NDC 00603-0441-50)
Bacitracin 500 unit/gram Ointment, Sandoz
0.9 gram foil packets, unit-dose, 144 count (NDC 00168-0111-09)
15 gram tube (NDC 00168-0011-35)
30 gram tube (NDC 00168-0011-31)
120 gram tube (NDC 00168-0011-04)
454 gram jar (NDC 00168-0011-16)
Estimated Resupply Dates
All presentations are currently available.
March 9, February 4 and 23, January 12, 2015; November 10, October 22, October 3, September 17, August 27, August 8, July 16, June 5, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins